| Literature DB >> 34285423 |
Julii Brainard1, Paul R Hunter1.
Abstract
Health misinformation can exacerbate infectious disease outbreaks. Especially pernicious advice could be classified as "fake news": manufactured with no respect for accuracy and often integrated with emotive or conspiracy-framed narratives. We built an agent-based model that simulated separate but linked circulating contagious disease and sharing of health advice (classified as useful or harmful). Such advice has potential to influence human risk-taking behavior and therefore the risk of acquiring infection, especially as people are more likely in observed social networks to share bad advice. We test strategies proposed in the recent literature for countering misinformation. Reducing harmful advice from 50% to 40% of circulating information, or making at least 20% of the population unable to share or believe harmful advice, mitigated the influence of bad advice in the disease outbreak outcomes. How feasible it is to try to make people "immune" to misinformation or control spread of harmful advice should be explored.Entities:
Keywords: Agent-based models; fake news; influenza; monkeypox; norovirus; social networks
Year: 2020 PMID: 34285423 PMCID: PMC8282656 DOI: 10.1177/0037549719885021
Source DB: PubMed Journal: Simulation ISSN: 0037-5497 Impact factor: 1.377
Model assumptions and targets (stage 1).
| Norovirus | Influenza | Monkeypox | |
|---|---|---|---|
|
| Insufficient data to estimate | ||
|
| Increase to 75% outbreaks have ≤7 generations | ||
|
| 2% | 2% | 1% |
|
| 36 hours (mean)[ | 48 h (mean), range 1–4 days; SD = 0.5 d[ | 12 d (mean)[ |
|
| Assumed none | Yes: 1 day before illness starts | Assumed none |
|
| Mean 48 hours | Only if illness <6 days | Assumed none |
|
| Entire duration of illness[ | First 6 days (mean) after symptoms onset, or until no longer
ill (if <6 days)[ | Entire duration of illness |
|
| 46 hours[ | 7 days, with | 21 d (mean)[ |
|
| 0% | 5%/d (when ill) | 70%/d (only after 4 d) |
|
| 0%[ | 0.65%[ | Low because assumed high-income country setting,
1–2%[ |
|
| No | After 5 months[ | After 18 wks[ |
|
| Not applicable | 100% if not incubating[ | 100% if <4 d after exposure, else 0[ |
|
| All those with TP >25th percentile of TP% & susceptible (or incubating <4 days if monkeypox) | ||
|
| If neither side takes enough precautions AND viral shed risk is high enough | ||
CFR: case fatality rate; p2p: person to person; TP: take-precautions; gens: generations.
Notes: targets are from the literature (influenza pandemics after 2009). The CFR for monkeypox is plausible,[65] but there is a lack of data from high-income country settings. The model assumes no shortage of vaccines (once available, there is always enough to meet demand). Delay in influenza is for production timeline; delay in monkeypox vaccine is for time to procure supply and to recognize need.
Performance metrics and results to generate stage 1–2 models.
| Norovirus | Influenza | Monkeypox | |
|---|---|---|---|
| Stage 1. Proportion of transmission risk due to viral
shedding | 8.3% | 3.6% | 0.8% |
| Stage 1. Mean case fatality rate % | n/a | 0.70% | 1.04% |
| Stage 2. ΔTP value required to consistently increase
| 1.9% | 1.05% | 1.1% |
| Stage 2. Mean case fatality rate % | n/a | 0.62% | 1.39% |
CFR: case fatality rate; gens: generations.
Note: these values most closely enabled meeting the r0 or #generations targets (in Table 1). Values in () are range of r0 or CFR, 5–95th percentiles, over ≥100 simulations. More detailed results are in the supplemental information.
Stage 1 (no sharing), stage 2 (outbreak exacerbated by bad advice), and stage 3 (results with intervention strategies). Mean values for given outbreak characteristics, with 5–95th percentiles to indicate range without the most extreme values.
| Duration (weeks) | Final attack rate | Peak attack rate | Case fatality rate | ||
|---|---|---|---|---|---|
| Norovirus | 1.90 (1.75–2.06) | 9.4 | 78.6% | 8.6% | n/a |
| Influenza | 1.46 (1.27–1.58) | 13.6 | 59.2% | 14.0% | 0.70% |
| Monkeypox | 75th perc #gens = 4 | 7.3 | 1.3% | 0.98% | 1.04% |
|
| Duration (weeks) | Final attack rate | Peak attack rate | Case fatality rate | |
| Norovirus | 2.66 (2.44–2.89) | 8.7 | 91.8% | 10.7% | n/a |
| Influenza | 2.08 (1.78–2.32) | 14.9 | 82.7% | 18.2% | 0.62% |
| Monkeypox | 75th perc #gens = 7 | 9.9 | 2.2% | 1.2% | 1.39% |
| Good:bad advice ratio | Duration (weeks) | Final attack rate | Peak attack rate | Case fatality rate | |
| Norovirus | 59:41 | 9.2 | 79.2% | 8.9% | n/a |
| Influenza | 60:40 | 14.4 | 59.0% | 13.4% | 0.73% |
| Monkeypox | 61:39 | 7.1 | 7.3% | 1.0% | 1.33% |
|
| Duration (weeks) | Final attack rate | Peak attack rate | Case fatality rate | |
| Norovirus | 0.99 (0.95–1.03) | 3.9 | 21.1% | 3.9% | n/a |
| Influenza | 0.88 (0.76–0.99) | 5.1 | 12.8% | 5.0% | 0.74% |
| Monkeypox | 75th perc #gens = 3 | 5.6 | 1.2% | 1.0% | 0.96% |
| % “immunized” | Duration (weeks) | Final attack rate | Peak attack rate | Case fatality rate | |
| Norovirus | 20% | 9.3 | 78.5% | 8.9% | n/a |
| Influenza | 22.5% | 15.2 | 59.6% | 13.1% | 0.42% |
| Monkeypox | 20–40% | 6.9–8.4 | 1.3–1.5% | 0.98–1.04% | 0.86–1.34% |
|
| Duration (weeks) | Final attack rate | Peak attack rate | Case fatality rate | |
| Norovirus | 1.11 (1.03–1.22) | 5.0 | 31.6% | 4.8% | n/a |
| Influenza | 1.02 (0.88–1.13) | 7.1 | 22.4% | 7.5% | 0.15% |
| Monkeypox | 75th perc #gens = 3 | 5.6 | 1.2% | 1.0% | 0.96% |
Note: “immunized” means acquired perfect resistance against believing or sharing bad advice, rather than inability to catch norovirus, influenza, or monkeypox. 75th perc #gens is the 75th percentile value (among all eligible simulations) for number of disease transmission generations; 75% of simulations had this number or fewer transmissions. Statistical significance: Wilcoxon rank sum tests with stage 1 outcomes as reference: ** means p < 0.01, while * means 0.01 < p < 0.05.